Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: US Biotech LIB Partners In Greater China With Hasten On PCSK9 Therapy

Asia Deal Watch — • Source: Alamy

Related Content

Deals Shaping the Medical Industry, October 2016

Oct 10 2016

Sandoz Fills Pipeline Gap With Samsung Bioepis’ Ustekinumab

Sep 11 2023

LIB Therapeutics Has An Unorthodox Funding Method And Big Plans

Aug 31 2023

Otsuka Adds To CNS Pipeline With Mindset Acquisition

Sep 01 2023

Otsuka Expands Ocular Gene Therapy Interests Through ShapeTX Deal

Sep 13 2023

India M&A Hourglass: Control Deals, ‘FOMO’, Monetization Calls At Family-Owned Firms

Sep 12 2023

More Interest In Speculated Cipla Stake Sale: Portfolio, Cultural Fit Will Matter

Sep 04 2023

Related Companies

LIB Therapeutics, LLC

Hasten Biopharmaceutic Co., Ltd.

Medpace Inc.

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Astellas Pharma, Inc.

Fortress Biotech Inc.

Journey Medical Corp.

Maruho Co., Ltd.

Zenas BioPharma

Huadong Medicine Co.,Ltd

MC2 Therapeutics A/S

Salipro Biotech AB

Sumitomo Pharma Co., Ltd.

Shanghai Henlius Biotech Co. Ltd.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

IMIDomics, Inc.

XtalPi, Inc.

Incendia Therapeutics

VistaGen Therapeutics, Inc.

Fuji Pharma Co. Ltd.

Twist Bioscience Corporation

Ono Pharmaceutical Company, Ltd.

Handok

argenx N.V.

Additional Topics

Asia Pacific Business Strategies Deals Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window